Yale Hematology Oncology Fellows

Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙

The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️

Super high yield lecture on sickle cell acute pain crises for IM residents, by THE Dr Jennifer Afranie-Sakyi 🙌🙌 @YaleHemOnc

What an incredible opportunity the Dixwell Community House provided chief @KwarambaT90 to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.

What happens at Miami nights stays at Miami nights. #ASCO25 @curtperrymdphd @ynie_md @Rajalsharma3

.@ThejalSrikumar and @KwarambaT90 highlight a new format @YaleHemOnc fellowship for teaching pharmacology using case-based, interdisciplinary, disease-specific curriculum. #ASCO25 @SmilowCancer @YaleMed @YNHH meetings.asco.org/abstracts-pres…

.@CostaPhilippos shared results of a phase 2 trial using Olaparib in IDH1 and IDH2 mutant #chondrosarcomas. Olaparib did not demonstrate activity, emphasizing the urgent need for additional therapeutic options. #ASCO25 @OncoAlert @SmilowCancer @YaleHemOnc meetings.asco.org/abstracts-pres…

Join us LIVE tonight at 6pm for this Spring's final #SmilowShares with Primary Care on #ColorectalCancer. Presenters include @DrPiyalAlam, @ThejalSrikumar, and Dr. Xavier Llor. ➡️bit.ly/45D2IE1 @SmilowCancer @YaleMed @YNHH @ynhhealth @YaleGICancers

Research led by @ncasasanta @YaleBreast assessed the TP53 Y220C mutation landscape in clinically advanced #breastcancer (CABC) and found it to be a relatively rare event in CABC. #ASCO25 @OncoAlert @SmilowCancer @YaleHemOnc meetings.asco.org/abstracts-pres…

@YaleCancer @YaleMed @ASCO annual meeting #Day4 poster presentations 👏🏼

This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!

This afternoon at 1:30pm CDT #ASCO25, @JuanJVelasco, @KwarambaT90, and @CostaPhilippos share new research advances from Yale in the final poster session of the day. @SmilowCancer @YaleMed @YNHH @YaleHemOnc

.@curtperrymdphd presents #ASCO25 on a novel RNA sequencing approach to identify a resistance mechanism enriched in neuroendocrine tumors #NET, merkle cell carcinoma #MCC, and small cell lung cancer #SCLC. @YaleHemOnc @SmilowCancer @OncoAlert meetings.asco.org/2025-asco-annu…

We have great representation in this morning's #ASCO25 poster session in Hall A! Stop by and support our presenters: @KashimaMDPhD, @tarasanftmd, @yoc42411, Ro Malik, @BraunMDPhD, @AartiBhatiaMD, @ncasasanta, Jing Du @YaleBreast, and Ismail Ajjawi. @SmilowCancer @YaleMed @YNHH…

On National #CancerSurvivorsDay, @KwarambaT90 presents new research outlining the risk of second primary cancers in long-term cancer survivors to help guide survivorship care and surveillance. #ASCO25 @YaleHemOnc @SmilowCancer @OncoAlert meetings.asco.org/abstracts-pres…